However, one may hypothesize that the worse prognosis of serum COMP positive patients under the treatment of taxanes is due to COMP-mediated apoptotic resistance by a similar calcium metabolism related mechanism as described in prostate cancer (2). The gene discussed is COMP; the disease is prostate carcinoma.